T1	Participants 80 168	metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study
T2	Participants 609 737	Between January 1988 and December 1992, 231 patients with estrogen receptor (ER)-positive or ER-unknown metastatic breast cancer
